Stock screener · US · NASDAQ
Filter the global stock universe by sector, market cap, P/E, ROE, dividend yield, and more. Covered tickers show our latest rating, fair value, and upside; data-only tickers still get profile, valuation, profitability, growth, ownership, and market indicators. For curated editorial screens (wide-moat, dividend aristocrats, etc.), see stock lists.
900
rows · refreshed 2026-05-10
| Symbol | Company | Market | Sector | Price | Market cap | P/E | ROE | 1Y return | Analysis |
|---|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. Drug Manufacturers - General | US / NASDAQ | Healthcare | $332 | 179B | 23.1x | +101.3% | +24.0% | Strong Buy$505 · +53.6% |
| GILD | Gilead Sciences, Inc. Drug Manufacturers - General | US / NASDAQ | Healthcare | $131 | 163.1B | 17.9x | +43.4% | +36.3% | Hold$132 · -1.2% |
| ISRG | Intuitive Surgical, Inc. Medical Instruments & Supplies | US / NASDAQ | Healthcare | $450 | 159.4B | 54.7x | +17.2% | -16.1% | Sell$255 · -43.4% |
| VRTX | Vertex Pharmaceuticals Incorporated Biotechnology | US / NASDAQ | Healthcare | $430 | 109.1B | 25.5x | +24.2% | -1.1% | Strong Buy$574 · +33.6% |
| SNY | Sanofi Drug Manufacturers - General | US / NASDAQ | Healthcare | $43.31 | 103.3B | 11.9x | +6.6% | -11.1% | Buy$51.16 · +17.5% |
| REGN | Regeneron Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $715 | 72.7B | 17.4x | +14.5% | +28.1% | Strong Buy$1,210 · +69.2% |
| MDLN | Medline Inc. Medical Instruments & Supplies | US / NASDAQ | Healthcare | $39.52 | 51.9B | 34.6x | +6.0% | n/a | Data only |
| ARGX | argenx SE Biotechnology | US / NASDAQ | Healthcare | $782 | 49.1B | 33.0x | n/a | +25.6% | Strong Buy$1,486 · +86.3% |
| IDXX | IDEXX Laboratories, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | $560 | 44.2B | 41.2x | +72.9% | +15.1% | Sell$335 · -37.2% |
| ALNY | Alnylam Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $295 | 39.4B | 74.7x | +90.4% | +6.7% | Strong Buy$666 · +128.0% |
| ONC | BeOne Medicines AG Biotechnology | US / NASDAQ | Healthcare | $312 | 34.7B | 70.9x | +12.4% | +34.4% | Data only |
| RVMD | Revolution Medicines, Inc. Biotechnology | US / NASDAQ | Healthcare | $142 | 30.1B | n/a | -76.7% | +276.6% | Data only |
| RPRX | Royalty Pharma plc Biotechnology | US / NASDAQ | Healthcare | $50.79 | 29.2B | 26.8x | n/a | +58.8% | Data only |
| GEHC | GE HealthCare Technologies Inc. Medical Devices | US / NASDAQ | Healthcare | $63.47 | 28.9B | 15.2x | +19.5% | -7.6% | Data only |
| BIIB | Biogen Inc. Drug Manufacturers - General | US / NASDAQ | Healthcare | $193 | 28.6B | 20.8x | +7.7% | +65.0% | Strong Buy$253 · +26.9% |
| NTRA | Natera, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | $194 | 27.8B | n/a | -15.0% | +21.3% | Data only |
| UTHR | United Therapeutics Corporation Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | $565 | 24B | 20.9x | +20.3% | +84.1% | Data only |
| BNTX | BioNTech SE Biotechnology | US / NASDAQ | Healthcare | $94.13 | 23.8B | n/a | -6.7% | +1.4% | Data only |
| DXCM | DexCom, Inc. Medical Devices | US / NASDAQ | Healthcare | $60.61 | 23.4B | 25.9x | +35.6% | -27.3% | Data only |
| INSM | Insmed Incorporated Biotechnology | US / NASDAQ | Healthcare | $101 | 22B | n/a | -294.5% | +48.4% | Data only |
| MRNA | Moderna, Inc. Biotechnology | US / NASDAQ | Healthcare | $54.35 | 21.6B | n/a | -36.6% | +125.9% | Hold$58.30 · +9.4% |
| ILMN | Illumina, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | $142 | 21.5B | 25.7x | +33.8% | +85.8% | Sell$98.39 · -32.5% |
| ROIV | Roivant Sciences Ltd. Biotechnology | US / NASDAQ | Healthcare | $28.56 | 20.4B | n/a | -19.1% | +155.7% | Data only |
| VTRS | Viatris Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | $17.17 | 20B | n/a | -2.0% | +109.0% | Data only |
| INCY | Incyte Corporation Biotechnology | US / NASDAQ | Healthcare | $98.56 | 19.7B | 14.0x | +30.8% | +65.5% | Data only |
| GMAB | Genmab A/S Biotechnology | US / NASDAQ | Healthcare | $26.43 | 15.9B | 19.3x | +15.0% | +28.3% | Data only |
| NBIX | Neurocrine Biosciences, Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | $152 | 15.3B | 23.4x | +22.5% | +25.2% | Data only |
| ASND | Ascendis Pharma A/S Biotechnology | US / NASDAQ | Healthcare | $239 | 14.8B | 25.8x | +332.7% | n/a | Data only |
| RGC | Regencell Bioscience Holdings Limited Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | $29.28 | 14.5B | n/a | -177.7% | +485.6% | Data only |
| JAZZ | Jazz Pharmaceuticals plc Biotechnology | US / NASDAQ | Healthcare | $226 | 14.2B | 481.0x | +0.7% | +122.6% | Data only |
| SMMT | Summit Therapeutics Inc. Biotechnology | US / NASDAQ | Healthcare | $18.08 | 14B | n/a | -271.0% | -25.6% | Data only |
| BBIO | BridgeBio Pharma, Inc. Biotechnology | US / NASDAQ | Healthcare | $67.39 | 13.2B | n/a | n/a | +88.1% | Data only |
| GH | Guardant Health, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | $95.70 | 12.7B | n/a | n/a | +140.8% | Data only |
| IONS | Ionis Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $75.71 | 12.5B | n/a | -67.6% | +128.9% | Data only |
| MEDP | Medpace Holdings, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | $424 | 12.1B | 26.7x | +77.3% | +41.3% | Data only |
| EXEL | Exelixis, Inc. Biotechnology | US / NASDAQ | Healthcare | $48.16 | 12.1B | 15.9x | +41.0% | +30.8% | Data only |
| ALGN | Align Technology, Inc. Medical Instruments & Supplies | US / NASDAQ | Healthcare | $169 | 12.1B | 28.4x | +10.8% | -2.0% | Data only |
| MDGL | Madrigal Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $510 | 11.8B | n/a | -49.3% | +70.7% | Data only |
| COO | The Cooper Companies, Inc. Medical Instruments & Supplies | US / NASDAQ | Healthcare | $60.00 | 11.7B | 29.9x | +4.9% | -26.2% | Data only |
| BTSG | BrightSpring Health Services, Inc. Health Information Services | US / NASDAQ | Healthcare | $54.83 | 11.3B | 71.4x | +9.2% | +138.0% | Data only |
| AXSM | Axsome Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | $217 | 11.2B | n/a | -349.4% | +96.1% | Data only |
| PODD | Insulet Corporation Medical Devices | US / NASDAQ | Healthcare | $154 | 10.7B | 35.9x | +23.0% | -41.7% | Data only |
| BMRN | BioMarin Pharmaceutical Inc. Biotechnology | US / NASDAQ | Healthcare | $54.06 | 10.4B | 38.7x | +4.5% | -8.9% | Data only |
| ARWR | Arrowhead Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | $72.69 | 10.2B | n/a | -42.4% | +456.6% | Data only |
| ENSG | The Ensign Group, Inc. Medical Care Facilities | US / NASDAQ | Healthcare | $171 | 9.9B | 27.9x | +16.9% | +25.4% | Data only |
| ABVX | ABIVAX Société Anonyme Biotechnology | US / NASDAQ | Healthcare | $123 | 9.8B | n/a | -135.6% | +1752.7% | Data only |
| CYTK | Cytokinetics, Incorporated Biotechnology | US / NASDAQ | Healthcare | $76.91 | 9.6B | n/a | n/a | +132.8% | Data only |
| ICLR | ICON Public Limited Company Diagnostics & Research | US / NASDAQ | Healthcare | $124 | 9.5B | 16.7x | +6.3% | -10.3% | Data only |
| MASI | Masimo Corporation Medical Devices | US / NASDAQ | Healthcare | $178 | 9.3B | 44.1x | +25.0% | +18.8% | Data only |
| PRAX | Praxis Precision Medicines, Inc. Biotechnology | US / NASDAQ | Healthcare | $330 | 9.2B | n/a | -35.3% | +766.4% | Data only |